Peptide Science 101: What Makes Research-Grade Compounds Real

Mass spectrometry measures identity, not purity. The instrument ionizes the sample and measures mass-to-charge ratio, yielding a molecular weight that can be compared against the calculated theoretical value for the intended sequence. Tandem mass spectrometry (LC-MS/MS) goes further by fragmenting the molecule and reading fragment masses, which reconstructs sequence information rather than just total mass. Coupled to liquid chromatography, LC-MS/MS provides separation and identification in one analytical run.

As peptides.so notes, neither test detects bacterial endotoxin, microbial contamination, residual solvents, or non-UV-absorbing impurities. A defensible research peptide Certificate of Analysis includes both HPLC and mass spectrometry data, along with bacterial endotoxin testing and lot-specific traceability.

What Should a Certificate of Analysis Actually Contain?

A Certificate of Analysis (CoA) is a record of tests performed on a specific quantity of material produced at a specific time. The entire concept depends on traceability: a CoA that is not tied to a lot number is not a certificate of analysis—it is a specification sheet describing what the supplier intends to produce.

A usable CoA must carry:

• Lot or batch identifier matching the label on the vial
• Test date (a CoA dated well before material synthesis describes a different lot)
• Compound name and molecular weight (compare the stated molecular weight against the published value for that sequence)
• HPLC chromatogram, not only a purity percentage—examine the baseline and look for shoulders or satellite peaks on the target
• Mass spectrometry result reporting an actual measured mass, not a restated theoretical value
• Endotoxin result with a numeric value and stated specification (e.g., <0.5 EU/mg), not just a "pass"
• Testing laboratory name and whether it is the manufacturer or an independent, ISO/IEC 17025-accredited facility

According to peptides.so, a CoA lacking a real lot number, date, and chromatogram is a marketing document formatted to look analytical. Without a real CoA, researchers have no independent verification of what is in the vial—they are taking the vendor's word.

What Does Endotoxin Testing Actually Tell You?

The Limulus amebocyte lysate (LAL) assay detects bacterial endotoxin—lipopolysaccharide from the outer membrane of Gram-negative bacteria. The reagent is derived from horseshoe crab hemolymph, which clots in the presence of endotoxin. Results are reported in endotoxin units per milligram (EU/mg).

What LAL does not measure is equally important. It does not detect Gram-positive bacteria, fungi, mycoplasma, or viruses. It does not establish sterility—a preparation can be endotoxin-free and still carry viable organisms. It does not detect non-endotoxin pyrogens. A low LAL result is one specific piece of information, not a general cleanliness certificate.

According to peptides.so, for research-grade peptides, <5 EU/mg is the general standard, though specifications vary by intended use. A CoA that reports only "Passes LAL" without a numeric result and specification is a weaker claim than it appears—pass against what threshold, measured how?

Why Do Purity and Provenance Matter Differently?

Purity is calculated as area under the curve: the software integrates the area of every peak, divides the target peak's area by the total area of all peaks, and reports the result as a percentage. This is a proportion, not an inventory. A peptide can be genuinely ≥99% pure and still contain unknown impurities that HPLC cannot distinguish.

Provenance refers to the chain of custody, manufacturing conditions, and third-party verification. A serious supplier operates by making material via solid-phase peptide synthesis, purifying it by preparative reverse-phase chromatography, and characterizing it by at least two orthogonal analytical methods before release. This does not mean the material was produced under pharmaceutical GMP or that any regulator has reviewed the facility—it means the process is documented and repeatable.

According to peptides.so, a legitimate CoA is valuable but should not be overinterpreted. A CoA does not automatically establish complete chain of custody, representativeness of every vial, sterility, exact net peptide content, long-term stability, or suitability for any specific application.

What Are the Red Flags in a Peptide Supplier's Documentation?

Researchers evaluating peptide suppliers should verify:

1. Lot-to-vial matching: Find the lot or batch number on the CoA and confirm it matches the number printed on the vial label. If the vial has no lot number, the document cannot be tied to the material.
2. Chromatogram visibility: Look at the actual HPLC chromatogram, not only the purity figure. Check the baseline and look for shoulders or satellite peaks on the target peak.
3. Mass spectrometry confirmation: Confirm the result reports an actual measured mass rather than a restated theoretical value. The ionization technique (ESI or MALDI) should be specified.
4. Endotoxin specification: Check for a numeric value and stated specification, not just a pass/fail claim.
5. Testing independence: Identify whether testing was performed by the manufacturer or an independent, accredited laboratory.
6. Counterion and net content: Verify explicit identification of the salt form (TFA salt, acetate salt, etc.) and net peptide content where applicable.

According to peptides.so, premium-grade research material typically includes ISO/IEC 17025-accredited release testing rather than in-house-only purity claims.

What Questions Should Researchers Ask About Peptide Compounds?

When investigating peptides such as sermorelin, tesamorelin, GHK-CU, BPC-157, TB-500, or other research compounds, researchers benefit from asking:

• Is the identity confirmed by LC-MS/MS? HPLC purity alone is insufficient.
• Does the CoA include a chromatogram and mass spectrum? Numeric results without supporting data are incomplete.
• Is the lot number on the CoA tied to the vial label? Undated or unlabeled CoAs are not batch-specific.
• What is the endotoxin specification and method? Generic "passes LAL" claims lack quantitative meaning.
• Was the material tested by an independent laboratory? Third-party verification strengthens confidence.
• What is the net peptide content? Counterion weight affects actual peptide quantity.

Key Takeaway: Reproducibility, Not Safety

Research-grade peptide standards exist to ensure reproducibility and traceability for scientific investigation, not to establish safety for human consumption. A well-characterized peptide with a rigorous CoA is suitable for cell culture, in vitro assays, or mechanistic studies—not for clinical use or human administration. Researchers must maintain this distinction and use peptides only within their intended research context.

The scientific credibility of peptide research depends on the quality of the starting material. Understanding how to read a Certificate of Analysis, distinguish between purity and identity, and evaluate supplier documentation is as fundamental to peptide science as proper experimental design and statistical analysis.